California Petitioner Seeks to Halt New York’s Cannabis Licensing
New york Cannabis Licensing Regime Faces Another Legal Challenge
Federal Appeals Court Hears Arguments on Dormant Commerce Clause
New York, NY – A California attorney is challenging New York’s cannabis dispensary licensing program, arguing that it unfairly favors in-state applicants and violates the dormant commerce clause. The case, heard by the U.S. Court of Appeals for the Second Circuit in Manhattan on Thursday, adds another layer of complexity to the already troubled rollout of New York’s recreational cannabis market.
Jeffrey Jensen, representing Variscite NY Four and Variscite NY Five, argued that New York’s “extra priority” system, which gives preference to applicants wiht past cannabis convictions in New York, discriminates against those with convictions in other states. Jensen, who is a minority owner of the companies and has partnered with social equity applicants with california convictions, claims this violates the dormant commerce clause, which prohibits states from enacting laws that unduly burden interstate commerce.
“New York’s program wasn’t initially clear about favoring New Yorkers,” Jensen stated. “It wasn’t until a month later that it became apparent that the cannabis conviction had to be under New York law.” He argued that this sudden shift disadvantaged out-of-state applicants who had already invested time and resources in forming their businesses.
Though, Alexandria Twinem, an assistant solicitor general representing New York, countered that the dormant commerce clause doesn’t apply to cannabis as Congress hasn’t legalized interstate commerce of the product. She also argued that Variscite’s claim of harm is minimal,as they would have had time to meet the requirements for the December 2023 application deadline.
The legal battle comes at a critical juncture for New York’s cannabis industry. A state court injunction issued in December halted the processing of Conditional Adult-Use Retail Dispensary (CAURD) license applications that hadn’t secured a location by November 17, 2023. This injunction, coupled with the federal appeal, further complicates the licensing process and casts uncertainty over the future of the program.
One of the judges questioned whether the case was ripe for a decision,noting that Variscite is 816th on the list of “extra priority” applicants and cannot yet claim constitutional injury due to the state court injunction.The federal appeals court is now tasked with determining whether the dormant commerce clause applies to New York’s cannabis licensing regime, a question that has been debated in multiple federal courts. The outcome of this case could have significant implications for the future of cannabis legalization and interstate commerce across the country.
New York Cannabis Licensing Program Faces Dormant Commerce Clause Challenge
[CITY, STATE] - The rollout of New York’s recreational cannabis market faces another hurdle as a federal appeals court grapples with a legal challenge to the state’s dispensary licensing program.
California attorney Jeffrey Jensen, representing Variscite NY Four and Variscite NY Five, argues that New York’s “extra priority” system, which favours applicants with past cannabis convictions in the state, unfairly discriminates against out-of-state applicants, violating the dormant commerce clause.
Jensen, who is a minority owner of the companies and has partnered with social equity applicants with California convictions, asserts that the program’s ambiguity regarding the location requirement for convictions disadvantages those who have already invested in establishing their businesses.
Assistant Solicitor General Alexandria Twinem, representing New York, countered that the dormant commerce clause doesn’t apply to cannabis due to its illicit status under federal law. Twinem further argued that Variscite’s claim of harm is minimal as they would still have time to meet the December 2023 request deadline.
This legal battle intensifies the challenges facing New York’s cannabis industry. A December state court injunction halted the processing of Conditional Adult-Use Retail Dispensary (CAURD) license applications that hadn’t secured a location by November 17,2023,adding further complexity to the licensing process.
The federal appeals court must now determine if the dormant commerce clause applies to New York’s cannabis licensing regime. This decision could have far-reaching implications for cannabis legalization and interstate commerce nationwide.
One judge raised concerns about the case’s ripeness for a decision, noting that Variscite, positioned 816th on the “extra priority” list, cannot yet demonstrate constitutional injury due to the state court injunction.